Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease c syndrome
Comorbidity C0006142|breast cancer
Sentences 23
PubMedID- 21490772 Two population-based screening surveys involving norwegian women found that low hdl-cholesterol, as part of the metabolic syndrome, is associated with increased post-menopausal breast cancer risk, and hdl-cholesterol association was confined to women in the heavier subgroup with body mass index (bmi) ≥25 kg/m2 [50].
PubMedID- 26030767 Results: presence of metabolic syndrome was associated with significantly increased breast cancer risk in all women (hr 1.52, 95%ci 1.14-2.02).
PubMedID- 23981814 Results from those studies reported statistically significant higher prevalence of metabolic syndrome in breast cancer patients with respect to healthy ones (35% vs. 19%) after menopause.
PubMedID- 19851862 A statistically significant association of triple-negative breast cancer with the metabolic syndrome was observed.
PubMedID- 25979299 Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer.
PubMedID- 24783905 We must point out that cardiovascular disease risk conferred by metabolic syndrome may increase with breast cancer treatment.
PubMedID- 25233884 Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer.
PubMedID- 23275775 breast cancer presents with a paraneoplastic neurologic syndrome.
PubMedID- 25890160 Dm can be a clinical manifestation of a paraneoplastic syndrome in patients with breast cancer.
PubMedID- 21249376 Objective: this study was aimed to assess the prevalence of metabolic syndrome in patients with breast cancer and the independent effect of metabolic syndrome on breast cancer risk.
PubMedID- 20931277 Polymyositis (pm) is a very rare paraneoplastic syndrome in association with breast cancer, here we present a breast cancer patient with a sudden onset of respiratory failure caused by pm.
PubMedID- 20584690 [features of preoperative contrast-enhanced ultrasound of breast cancer: relationship with the syndrome classification in traditional chinese medicine].
PubMedID- 25095302 The case report features a patient who had a diagnosis of a common type of breast cancer with an uncommon neurologic syndrome.
PubMedID- 19361966 Presence of three or more metabolic syndrome components) was significantly associated with breast cancer risk (rate ratio 1.58 [95% confidence interval 1.07-2.33]), with a significant risk increase for increasing number of components (p for trend 0.004).
PubMedID- 25979298 Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer.
PubMedID- 26175188 Adherence to wcrf/aicr cancer prevention recommendations and metabolic syndrome in breast cancer patients.
PubMedID- 19847590 Aosd has been reported as one of paraneoplastic syndromes associated with breast cancer.
PubMedID- 24319454 Due to a higher prevalence of metabolic syndrome in breast cancer survivors, lifestyle interventions are needed to prevent chronic diseases associated with obesity.
PubMedID- 25653879 Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis.
PubMedID- 22740197 Several studies have examined the association of the individual components of the metabolic syndrome with breast cancer.
PubMedID- 24344007 The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients.
PubMedID- 25083463 Metabolic syndrome in breast cancer.
PubMedID- 23227958 The authors hypothesized that the higher prevalence of abdominal obesity and metabolic syndrome among women with triple-negative breast cancer and its link to adrenergic dysregulation and also high expression of beta-adrenergic receptors in triple-negative breast cancer cell lines could make these patients particularly sensitive to beta-blocker treatment.

Page: 1